Theme · live manifest · live theme JSON

MedTech Long '24: Diagnostics & Monitoring

8 tickers · $75.23B total market cap

Group: MedTech Long

The MedTech '24: Diagnostics & Monitoring subtheme is currently bullish as of Spring 2025. The sector is expected to benefit from increasing demand for advanced diagnostic and monitoring solutions due to rising chronic disease prevalence and an aging population. Technological advancements in genomics and personalized medicine are driving growth in companies like ILMN and EXAS. However, regulatory changes and potential reimbursement pressures remain risks.

MedTech Long '24: Diagnostics & Monitoring tracks 8 publicly listed stocks in this theme: CSTL, DXCM, EXAS, GRAL, ILMN, IRTC, NEO, QDEL. See the constituent table for details.

Thesis update: 2025-04-01

Constituents

Build 20260520T081747

CompanyPrevious Quarter Report DateNext Expected Report DateLast Quarter Earnings Move %Earnings Move %Intra-Quarter Move %Since Last Report %Market capWeight
DexCom, Inc.DXCM
04/30/2026 (AMC)04/30/2026 (AMC)7.59%6.58%-14.95%9.13%$25.83B12.5000
Illumina, Inc.ILMN
04/30/2026 (AMC)04/30/2026 (AMC)-10.40%12.80%5.86%4.35%$21.44B12.5000
Exact Sciences CorporationEXAS
02/13/2026 (AMC)0.00%1.62%$20.03B12.5000
iRhythm Technologies, Inc.IRTC
04/30/2026 (AMC)04/30/2026 (AMC)-4.98%0.04%-14.44%-5.76%$3.74B12.5000
GRAIL, Inc.GRAL
05/05/2026 (AMC)05/05/2026 (AMC)-50.55%12.74%8.35%-2.80%$2.62B12.5000
QuidelOrtho CorporationQDEL
05/05/2026 (AMC)05/05/2026 (AMC)-18.12%-11.76%-50.55%3.83%$776.0M12.5000
Castle Biosciences, Inc.CSTL
05/06/2026 (AMC)05/06/2026 (AMC)-7.25%-21.79%-16.30%-0.21%$582.3M12.5000
NeoGenomics, Inc.NEO
04/28/2026 (BMO)04/28/2026 (BMO)-9.84%4.07%-16.08%-6.36%$218.5M12.5000
Average-11.69%0.38%-12.06%0.31%$9.40B12.5000
Median-8.54%4.07%-14.70%-0.21%$3.18B12.5000
Std Dev16.32%11.94%17.52%5.32%$10.26B0.0%
Min-50.55%-21.79%-50.55%-6.36%$218.5M12.5000
Max7.59%12.80%8.35%9.13%$25.83B12.5000
% Positive Tickers12.50%71.43%37.50%42.86%

* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.

← All themes